Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

Makoto Natsume,Takaya Shimura,Hiroyasu Iwasaki,Yusuke Okuda,Mika Kitagawa,Yasuyuki Okamoto,Kazuki Hayashi,Hiromi Kataoka

Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

2019

Makoto Natsume
Takaya Shimura
Hiroyasu Iwasaki
Yusuke Okuda
Mika Kitagawa
Yasuyuki Okamoto
Kazuki Hayashi
Hiromi Kataoka

Purpose Ramucirumab (RAM) has been used as the second-line standard chemotherapy for advanced gastric cancer (AGC) either alone or combination with paclitaxel (PTX). However, no predictive biomarkers have been identified for RAM treatment in AGC.

Keywords:

Pharmacology
Oncology
Cancer
Angiogenesis
Biomarker (medicine)
Paclitaxel
Internal medicine
Placental growth factor
VEGF receptors
Medicine
Ramucirumab
Chemotherapy
predictive biomarker
advanced gastric cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations